Status:
COMPLETED
To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days
Lead Sponsor:
Pfizer
Collaborating Sponsors:
McLean Hospital. Belmont, MA.
Conditions:
Infections, Fungal
Eligibility:
MALE
18-55 years
Phase:
PHASE4
Brief Summary
To determine the amount of voriconazole in the brain after 2 loading doses and 3 maintenance doses over 3 days and compare it to the amount of voriconazole in the plasma.
Eligibility Criteria
Inclusion
- Subjects must be willing and able to provide informed consent.
- Subjects must be willing and able to be confined at the Clinical Research Unit as required by the protocol.
Exclusion
- Subjects with any condition affecting drug absorption.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00300677
Start Date
March 1 2007
End Date
August 1 2008
Last Update
October 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Belmont, Massachusetts, United States, 02478-1041